We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shield Therapeutics Plc | LSE:STX | London | Ordinary Share | GB00BYV81293 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.20 | 9.76% | 2.25 | 2.20 | 2.30 | 2.25 | 2.05 | 2.05 | 14,618,833 | 10:05:51 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 4.47M | -40.44M | -0.0522 | -0.40 | 16.28M |
Date | Subject | Author | Discuss |
---|---|---|---|
19/1/2020 22:04 | Business update due in a few days time, last year it was on Thursday 24 January. Norgine deal royalty rate is 25% to 40%, likely 25% till the next sales milestone, so every 1 million GBP STX product sales revenue equals 4 million GBP in market sales of Feraccru. Hardman expect STX 2019 product sales of 610,000 GBP reflecting maybe 2.44 million GBP in market sales, up from 0.9 million GBP for 2018. This represents a 170 percent increase in year on year in market sales. Every month without a US deal reduces US peak sales patent period with expected in market sales loss of 27 million GBP per month. There must be an important reason for holding back on announcing that deal? | borromini1 | |
18/1/2020 08:38 | For info. An easily digested description of the importance of iron to our body. hxxps://www.spatone. | hashertu | |
18/1/2020 06:30 | stalker Says it all but Defensive Sector springs to mind | best1467 | |
17/1/2020 14:16 | Yes a nice correction, bear trap, for the long term holders just a great opportunity to add, if required, or you those following for a while but not invested, a great opportunity to buy in, everyone do their own research, no advice intended. | ny boy | |
17/1/2020 14:04 | Catapult effect. Small time investors panicking. The more it pulls back , the better the rise that will come | peachie 74 | |
17/1/2020 14:00 | Lol, credibility it tatters, IGNORE, totally clueless Stalker_Boy Member since: 19 Dec 2019 As the share price corrects, very likely to attract strong buying interest imo | ny boy | |
17/1/2020 12:54 | Oh deary deary me.............can't even rise in a market rally so when the market falls next week then this will be hammered. | stalker_boy | |
17/1/2020 12:28 | English version of ASK Pharm website: hxxp://www.ask-pharm | ekcs | |
17/1/2020 12:26 | Re the appeal at the European Patent Office, even though the board of members has been appointed to hear the appeal, they told me the whole process can take between 2-4 years, so basically unless TEVA back down, it doesn’t look like it’s going anywhere anytime soon. I doubt if this will have any bearing on the China deal or the pending US commercialization deal either | ny boy | |
17/1/2020 08:05 | I totally agree peachy. Exactly the right view in my opinion. Outside of that just look at the trades - slots of 10k in repeat. To me someone that is selling a decent stake for probably a sensible reason to them. Anyway - now we wait and see | 2theduke | |
17/1/2020 05:47 | Current s/r levels Support1: 164.50 Support2: 136.86 Resistance1: 183.35 Resistance2: 195.00 | ny boy | |
16/1/2020 22:15 | It’s a funny time between the uncertainty that drives speculation and when the river of cash removes all doubt. I presume there’s a small market for derisked shares that don’t have a strong income stream but in all likelihood, will. When they do, they should rise gently so there will be time to get in, if you have a pension fund to manage. Just not right now. | crankyman | |
16/1/2020 21:10 | Have to keep faith in the share with the knowledge you have. Not the market trend on such low volumes. The share is de risked. US news to come. Plus more. Hardman price forecast 350 ( I think ) I’ve added today. Obviously hoping it’s the bottom. We will see. Good luck everyone. | peachie 74 | |
16/1/2020 20:23 | Thanks for that. Was struggling for background on ASK | crankyman | |
16/1/2020 19:15 | Just a a couple of Warming snippets from our new Chinese Partner.ASK pharma has Secured the Top National Innovators and Research and Development award which is a Peer reviewed award for Yes 9 consecutive years since 2010 and is widely recognised as one of the leading R&D Innovators and brand name Pharmaceuticals Manufacturers in China nota bad choice for a Partner. | best1467 | |
16/1/2020 16:43 | Invested nyboy, but find your 1000 top up amusing .How much is a load, your 1000 today is probably worth the same amount as your buys In the 30s ? | arab3 | |
16/1/2020 16:25 | Don't know people are adding...could drop lower thanks to to..CITY SCUMBAGS | kop202 | |
16/1/2020 15:54 | I have a load already, I have been buying since the 30p’s, I could still be tempted again on this low volume retrace though. Are you invested here or just passing through again? | ny boy | |
16/1/2020 15:54 | I have a load already, I have been buying since the 30p’s, I could still be tempted again on this low volume retrace though. Are you invested here or just passing through again? | ny boy | |
16/1/2020 15:02 | You going to double up again nyboy? Lol | arab3 | |
16/1/2020 14:55 | Jeez if arab3 has turned up with another classic post, it must be time to buy lol | ny boy | |
16/1/2020 14:49 | Okay so by mistake i bought 2 tranche... so total £16200. Phew!!! Shield Therapeutics plc Ordinary Shares 1.5p 16,077.60 -120.37 -0.74 n/a n/a 16,197.97 -6.50 -3.77 | marie1980 | |
16/1/2020 14:47 | Bought worth £8000. No brainer... Shield Therapeutics plc (STX) Ordinary Shares 1.5p 4932 shares bought at 165.99p Value: (Excl. stamp duty, commission and PTM levy) £8,186.63 PTM levy: £0.00 Commission: £11.95 Stamp duty: £0.00 Settlement date: 20/01/2020 Total value of trade: £8,198.58 | marie1980 | |
16/1/2020 14:26 | Bought a few more today as well along with some HEMO after yesterdays stellar news | knowing | |
16/1/2020 14:25 | Added 1000 last of the big spenders! Easy to see how you own every stock on the market lol | arab3 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions